Merck Issues Statement Regarding CUBICIN Patent Litigation; Says Reviewing Decision, Considering Next Steps
November 12, 2015 at 11:52 AM EST
Merck (NYSE: MRK), known as MSD outside the United States and Canada, issued the following statement regarding the ...